Is platelet activating factor (PAF) an important mediator in bronchial asthma?

The development of selective PAF receptor antagonists may provide a novel approach to the treatment of human bronchial asthma. In preclinical animal models of human asthma, PAF receptor antagonists have been found to be efficacious in blocking antigen-induced changes in lung function. However, the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Gundel, R. H., Heuer, H. O., Letts, L. G.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365369/
https://www.ncbi.nlm.nih.gov/pubmed/18475485
http://dx.doi.org/10.1155/S0962935192000541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365369/
https://www.ncbi.nlm.nih.gov/pubmed/18475485
http://dx.doi.org/10.1155/S0962935192000541

Ejemplares similares